Inside Washington: Major Changes Ahead for FDA
November 15, 2002
Jill WechslerJill Wechsler
Jill Wechsler is BioPharm International's Washington Editor, jillwechsler7@gmail.com.
BioPharm International, BioPharm International-11-01-2002, Volume 15, Issue 11
by Jill Wechsler A new FDA commissioner will have to oversee agency consolidation and new initiatives to counter bioterrorism.